- Correction
- Open access
- Published:
Correction to: Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)
BMC Cancer volume 20, Article number: 128 (2020)
The Original Article was published on 16 December 2019
Correction to: BMC Cancer
https://doi.org/10.1186/s12885-019-6271-3
Following publication of the original article [1], the authors reported that the family name of the author, Ludovica Baldari, was misspelled.
Incorrect:
Ludovica Baldarti
Correct:
Ludovica Baldari
Reference
Monsellato I, Alongi F, Bertocchi E, et al. Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). BMC Cancer. 2019;19:1215 https://doi.org/10.1186/s12885-019-6271-3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Monsellato, I., Alongi, F., Bertocchi, E. et al. Correction to: Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). BMC Cancer 20, 128 (2020). https://doi.org/10.1186/s12885-020-6632-y
Published:
DOI: https://doi.org/10.1186/s12885-020-6632-y